Reference:
Yasmin, F., Najeeb, H., Naeem, U., Moeed, A., Atif, A. R., Asghar, M. S., Nimri, N., Saleem, M., Bandyopadhyay, D., Krittanawong, C., Eljack, M. M. F., Tahir, M. J., & Waqar, F.
(2023). Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immunity, Inflammation and Disease, 11, e807. https://doi.org/10.1002/iid3.807
Summary:
This systematic review investigates cardiovascular complications linked to COVID-19 mRNA vaccines, specifically focusing on pericarditis, myocarditis, thrombosis, and strokes. An analysis of 81 studies encompassing 17,636 individuals revealed that the BNT162b2 (Pfizer-BioNTech) vaccine had the highest incidence of events, with thrombosis being the most frequently reported complication. The review highlights the need for further research into the adverse effects of the mRNA-1273 (Moderna) vaccine and stresses the importance of monitoring mortality rates associated with these vaccines. The findings suggest a critical evaluation of the risk-benefit ratio for vaccination, particularly in vulnerable populations.